trending Market Intelligence /marketintelligence/en/news-insights/trending/IWE0sW0a6v6CtlPUzaLx8Q2 content esgSubNav
In This List

Trillium closes $20M private placement

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


Trillium closes $20M private placement

Trillium Therapeutics Inc. closed a nonbrokered private placement of 1,950,000 common shares and 400,000 series II nonvoting convertible first preferred shares, both priced $8.50 apiece.

The company raised gross proceeds of about $20 million and plans to use net proceeds for product candidate development, working capital and general corporate purposes.

Cowen acted as sole placement agent.